Literature DB >> 10764587

PKC-zeta-associated CK2 participates in the turnover of free IkappaBalpha.

G D Bren1, K N Pennington, C V Paya.   

Abstract

The atypical PKC isoenzymes, zeta and iota, activate NF-kappaB, a mechanism thought to mediate the anti-apoptotic and proliferative features of these kinases. PKC-zeta has been shown to be associated with an IkappaBalpha kinase in resting cells. In this study, we have sought to identify the PKC-zeta associated kinase and understand how PKC-zeta mediates basal IkappaBalpha turnover in vivo. We demonstrate that the PKC-zeta-associated IkappaBalpha kinase is CK2. This kinase, previously shown to phosphorylate the PEST domain of IkappaB molecules, co-precipitates with PKC-zeta in resting cells. In vitro, PKC-zeta interacts with CK2-beta. The in vivo PKC-zeta-associated CK2 preferentially phosphorylates S293 of IkappaBalpha as compared to non-associated CK2. The functional relevance of this observation is supported by the fact that the turnover of free IkappaBalpha in resting cells is S293-dependent. Moreover, overexpressing PKC-zeta results in lower steady-state protein levels of free IkappaBalpha, which is dependent on S293. Lastly, it is shown that PKC-zeta wt but not kinase dead leads to the in vitro phosphorylation of both CK2-alpha and beta. These studies demonstrate that the association between CK2 and PKC-zeta may play a major role in the control of the basal turnover of free IkappaBalpha, in the absence of extracellular stimuli. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764587     DOI: 10.1006/jmbi.2000.3630

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Protein kinase CK2: a new view of an old molecular complex.

Authors:  Odile Filhol; Jean-Louis Martiel; Claude Cochet
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

2.  Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.

Authors:  Ming Yu; Jason Yeh; Carter Van Waes
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

3.  UV as an amplifier rather than inducer of NF-kappaB activity.

Authors:  Ellen L O'Dea; Jeffrey D Kearns; Alexander Hoffmann
Journal:  Mol Cell       Date:  2008-06-06       Impact factor: 17.970

4.  Protein kinase CK2: signaling and tumorigenesis in the mammary gland.

Authors:  E Landesman-Bollag; D H Song; R Romieu-Mourez; D J Sussman; R D Cardiff; G E Sonenshein; D C Seldin
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

5.  From calcium to NF-kappa B signaling pathways in neurons.

Authors:  Alain Lilienbaum; Alain Israël
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

7.  Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells.

Authors:  Katriina Kahlos; Jianliang Zhang; Edward R Block; Jawaharlal M Patel
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

8.  Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes.

Authors:  Anar Dossumbekova; Mirela Anghelina; Shashi Madhavan; Lingli He; Ning Quan; Thomas Knobloch; Sudha Agarwal
Journal:  Arthritis Rheum       Date:  2007-10

9.  Demonstration of subcellular migration of CK2α localization from nucleus to sarco(endo)plasmic reticulum in mammalian cardiomyocytes under hyperglycemia.

Authors:  Ceylan Verda Bitirim; Erkan Tuncay; Belma Turan
Journal:  Mol Cell Biochem       Date:  2017-10-20       Impact factor: 3.396

10.  A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity.

Authors:  Ellen L O'Dea; Derren Barken; Raechel Q Peralta; Kim T Tran; Shannon L Werner; Jeffrey D Kearns; Andre Levchenko; Alexander Hoffmann
Journal:  Mol Syst Biol       Date:  2007-05-08       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.